Writes Steve Berger:

Low cost generic that is effective for treatment or as prophylactic and hence an alarming threat to big pharmaceutical push for vaccines. Plus admitting it’s effectiveness would remove the emergency use authorization for the genetic experimental shots. Lew, I just keep returning again and again to Hans Hoppe’s essay honoring Rothbard for among other things being a great historian. He noted that a great historian has to answer the question of who benefits and secondly has to search in unconventional places to ferret out the truth including concealed memos, censored articles, footnotes buried in legislation etc.  We are witnessing classic regulatory capture driven by political and financial incentives.

See here.